Skip to main content

The Importance of Understanding Informed Consent

Researchers Discuss

This video presents interviews with experts on minority involvement in clinical trials. These include Dorothy Edwards, PhD, Dawn O. Kleindorfer, M.D., Alexander Dromerick, M.D., Jose G. Romano, M.D., Daniel Woo, M.D., and Kathryn France, R.N., P.H.N., C.C.R.C., C.C.R.A

Dromerick: We have to approach the recruiting effort from the perspective of the individual that we're trying to enroll in the study.

Woo: This is your choice. This is what we call an informed consent that gives you all the information that you need.

Capstraw: We want you to be informed during the entire process. And also, we want to incorporate your family and your loved ones in the entire process of the study.

Woo: You can go out and research what's going on in the study through your own investigations, through the internet, or what have you. And you can withdraw at any time that you wish to. Also, here's a number that you can call if you ever feel that we have exploited you or abused you in any way. And it's right here on this form, which you're going to receive a copy of.

Dromerick: One of the things that we take very seriously is privacy.

Reimer: Any information that we gather is private, and we keep it in our locked room, in a locked drawer, and I won't tell anybody any information about you and the study unless you ask me to.

Gorelick: People then will either be comfortable with us, and what we have to say, and what we stand for; or if they're not, then there's no match here and we can't randomize the patient.

 Other NIMICT Tools